Form 8-K - Current report:
SEC Accession No. 0001564590-21-057763
Filing Date
2021-11-19
Accepted
2021-11-19 16:01:45
Documents
22
Period of Report
2021-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-8k_20211116.htm   iXBRL 8-K 47674
2 EX-1.1 eypt-ex11_47.htm EX-1.1 378715
3 EX-4.1 eypt-ex41_93.htm EX-4.1 136010
4 EX-5.1 eypt-ex51_89.htm EX-5.1 16742
5 EX-99.1 eypt-ex991_90.htm EX-99.1 15179
6 EX-99.2 eypt-ex992_91.htm EX-99.2 16930
7 EX-99.3 eypt-ex993_92.htm EX-99.3 15679
8 GRAPHIC gntehswbbl2a000001.jpg GRAPHIC 5377
9 GRAPHIC gggq2btltwa4000001.jpg GRAPHIC 5377
10 GRAPHIC gx5wdwjaiczp000001.jpg GRAPHIC 5377
11 GRAPHIC gn3w044i2iuw000001.jpg GRAPHIC 28096
  Complete submission text file 0001564590-21-057763.txt   929839

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA eypt-20211116.xsd EX-101.SCH 5693
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20211116_lab.xml EX-101.LAB 18580
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20211116_pre.xml EX-101.PRE 11041
15 EXTRACTED XBRL INSTANCE DOCUMENT eypt-8k_20211116_htm.xml XML 3415
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 211428290
SIC: 3826 Laboratory Analytical Instruments